Involvement of the brain histaminergic system in addiction and addiction-related behaviors: A comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence

Progress in Neurobiology

Volumn 92, Issue 3, 2010, Pages 421-441

  Brabant, Christian ^a,b   Alleva, Livia ^b   Quertemont, Etienne ^b   Tirelli, Ezio ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Addiction; Dopamine; Histamine; Histamine H3 receptor; Reward

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ALCOHOL; AMPHETAMINE; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; COCAINE; CYCLIZINE; DEXCHLORPHENIRAMINE; DIMAPRIT; DIPHENHYDRAMINE; DIPHENYLPYRALINE; EBASTINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR AGONIST; HYDROXYZINE; KETOTIFEN; MEPYRAMINE; OPIATE; PHENIRAMINE; PROMETHAZINE; QUINPIROLE; RANITIDINE; TRIPELENNAMINE; TRIPROLIDINE; UNINDEXED DRUG; ZOLANTIDINE;

ANIMAL BEHAVIOR; BRAIN DEPTH STIMULATION; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; HISTAMINE RELEASE; HUMAN; LOCOMOTION; MESENCEPHALON; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; DOPAMINE; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; RECEPTORS, HISTAMINE; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 77956315070     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.07.002     Document Type: Review

References (186)

1. Acevedo S., Ohtsu H., Benice T., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res. 2006, 1071(1):113-123.
2. Akhtar M., Uma Devi P., Ali A., Pillai K., Vohora D. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice. Fundam. Clin. Pharmacol. 2006, 20(4):373-378.
3. Alakärppä K., Tupala E., Mantere T., Särkioja T., Räsänen P., Tarhanen J., Tiihonen J., Tuomisto L. Effect of alcohol abuse on human brain histamine and tele-methylhistamine. Inflamm. Res. 2002, 51(Suppl. 1):S40-S41.
4. Alakärppä K., Tupala E., Mantere T., Särkioja T., Räsänen P., Tarhanen J., Tiihonen J., Tuomisto L. Alcoholics show altered histaminergic neurotransmission in several cortical areas-preliminary report. Inflamm. Res. 2003, 52(Suppl. 1):S37-S38.
5. Ambroziak W., Pietruszko R. Human aldehyde dehydrogenase: metabolism of putrescine and histamine. Alcohol. Clin. Exp. Res. 1987, 11(6):528-532.
6. Arrang J., Garbarg M., Schwartz J. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983, 302(5911):832-837.
7. Barnett A., Iorio L., Kreutner W., Tozzi S., Ahn H., Gulbenkian A. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents Actions 1984, 14(5-6):590-597.
8. Beardsley P., Balster R. The intravenous self-administration of antihistamines by rhesus monkeys. Drug Alcohol Depend. 1992, 30(2):117-126.
9. Bell M.I., Richardson P.J., Lee K. Histamine depolarizes cholinergic interneurones in the rat striatum via a H(1)-receptor mediated action. Br. J. Pharmacol. 2000, 131(6):1135-1142.
10. Bergman J. Psychomotor stimulant effects of the stereoisomers of chlorpheniramine. Psychopharmacology 1990, 100(1):132-134.
11. Bergman J., Spealman R. Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J. Pharmacol. Exp. Ther. 1986, 239(1):104-110.
12. Bergman J., Spealman R. Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol. J. Pharmacol. Exp. Ther. 1988, 245(2):471-478.
13. Borgkvist A., Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci. Biobehav. Rev. 2007, 31(1):79-88.
14. Bouthenet M., Martres M., Sales N., Schwartz J. A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 1987, 20:117-155.
15. Bouthenet M., Ruat M., Sales N., Garbarg M., Schwartz J. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience 1988, 26(2):553-600.
16. Brabant C., Alleva L., Grisar T., Quertemont E., Lakaye B., Ohtsu H., Lin J.S., Jatlow P., Picciotto M., Tirelli E. Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology 2009, 202(4):673-687.
17. Brabant C., Charlier Y., Quertemont E., Tirelli E. The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav. Brain Res. 2005, 160(1):161-168.
18. Brabant, C., Grisar, T., Quertemont, E., Lakaye, B., Lin, J.S., Ohtsu, H., Brunzell, D.H., Tirelli, E., 2007a. Examination of the role of H3 receptors in the locomotor effects of cocaine. Abstract from the Society for Neuroscience, San Diego, CA, USA.
19. Brabant C., Quertemont E., Anaclet C., Lin J.S., Ohtsu H., Tirelli E. The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward. Psychopharmacology 2007, 190(2):251-263.
20. Brabant C., Quertemont E., Tirelli E. Effects of the H3-receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice. Pharmacol. Biochem. Behav. 2006, 83(4):561-569.
21. Bristow L.J., Bennett G.W. Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors. Br. J. Pharmacol. 1988, 95(4):1292-1302.
22. Bristow L.J., Bennett G.W. A role for histamine H3 receptors in histamine-induced hypoactiviy in the rat. Br. J. Pharmacol. 1988, 94(supplement):P319.
23. Burban A., Sadakhom C., Dumoulin D., Rose C., Le Pen G., Frances H., Arrang J.M. Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H(3)-receptor inverse agonists. Psychopharmacology 2010, 210(4):591-604.
24. Campbell V., Kopajtic T., Newman A., Katz J. Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. J. Pharmacol. Exp. Ther. 2005, 315(2):631-640.
25. Chazot P., Hann V., Wilson C., Lees G., Thompson C. Immunological identification of the mammalian H3 histamine receptor in the mouse brain. Neuroreport 2001, 12(2):259-262.
26. Chiavegatto S., Nasello A., Bernardi M. Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci. 1998, 62(20):1875-1888.
27. Chikai T., Oishi R., Saeki K. Increase in the extracellular histamine concentration in the rat striatum by mu-opioid receptor activation. J. Neurochem. 1994, 62(2):724-729.
28. Clapham J., Kilpatrick G. Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur. J. Pharmacol. 1994, 259(2):107-114.
29. Coelho J., Medalha C., Mattioli R. Analysis of the effects of CPA and L-histidine on goldfish tested on a conditioned place preference model. Behav. Brain Res. 2001, 124(2):161-165.
30. Cohn C., Ball G., Hirsch J. Histamine: effect on self-stimulation. Science 1973, 180(87):757-758.
31. Cousins M., Roberts D., de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 2002, 65(3):209-220.
32. Cumming P., Laliberté C., Gjedde A. Distribution of histamine H3 binding in forebrain of mouse and guinea pig. Brain Res. 1994, 664(1-2):276-279.
33. de Almeida M., Izquierdo I. Memory facilitation by histamine. Arch. Int. Pharmacodyn. Ther. 1986, 283(2):193-198.
34. Dere E., De Souza-Silva M., Topic B., Spieler R., Haas H., Huston J. Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover. Learn. Mem. 2003, 10(6):510-519.
35. Dringenberg H.C., De Souza-Silva M.A., Rossmuller J., Huston J.P., Schwarting R.K.W. Histamine H-1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus. J. Neurochem. 1998, 70(4):1750-1758.
36. Dringenberg H., de Souza-Silva M., Schwarting R., Huston J. Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch. Pharmacol. 1998, 358(4):423-429.
37. Endou M., Poli E., Levi R. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels. J. Pharmacol. Exp. Ther. 1994, 269(1):221-229.
38. Ericson H., Blomqvist A., Köhler C. Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation. J. Comp. Neurol. 1989, 281(2):169-192.
39. Esbenshade T.A., Browman K.E., Bitner R.S., Strakhova M., Cowart M.D., Brioni J.D. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br. J. Pharmacol. 2008, 154(6):1166-1181.
40. Evans S., Johanson C. Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J. Pharmacol. Exp. Ther. 1989, 250(3):779-787.
41. Ferrada C., Ferré S., Casadó V., Cortés A., Justinova Z., Barnes C., Canela E., Goldberg S., Leurs R., Lluis C., Franco R. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 2008, 55(2):190-197.
42. Ferrada C., Moreno E., Casadó V., Bongers G., Cortés A., Mallol J., Canela E., Leurs R., Ferré S., Lluis C., Franco R. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br. J. Pharmacol. 2009, 157(1):64-75.
43. Fleckenstein A., Lookingland K., Moore K. Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 347(1):50-54.
44. Fox G., Esbenshade T., Pan J., Radek R., Krueger K., Yao B., Browman K., Buckley M., Ballard M., Komater V., Miner H., Zhang M., Faghih R., Rueter L., Bitner R., Drescher K., Wetter J., Marsh K., Lemaire M., Porsolt R., Bennani Y., Sullivan J., Cowart M., Decker M., Hancock A. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J. Pharmacol. Exp. Ther. 2005, 313(1):176-190.
45. Frisch C., Hasenöhrl R., Haas H., Weiler H., Steinbusch H., Huston J. Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp. Brain Res. 1998, 118(4):447-456.
46. Frisch C., Hasenöhrl R.U., Huston J.P. The histamine H1-antagonist chlorpheniramine facilitates learning in aged rats. Neurosci. Lett. 1997, 229(2):89-92.
47. Galosi R., Lenard L., Knoche A., Haas H., Huston J., Schwarting R. Dopaminergic effects of histamine administration in the nucleus accumbens and the impact of H1-receptor blockade. Neuropharmacology 2001, 40(4):624-633.
48. Garrison J. Histamine, bradykinin, 5-hydroxytryptamine and their antagonists. Goodman and Gilman's: The Pharmacological Basis of Therapeutics 1990, 575-599. McGraw-Hill, New York. 8th ed. A. Gilman, T. Rall, A. Nies, P. Taylor (Eds.).
49. Gass J., Olive M. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 2008, 75(1):218-265.
50. Gong Y., Lv M., Zhu Y., Zhu Y., Wei E., Shi H., Zeng Q., Chen Z. Endogenous histamine inhibits the development of morphine-induced conditioned place preference. Acta Pharmacol. Sin. 2007, 28(1):10-18.
51. Gong Y., Wang H., Zhu Y., Zhang W., Dai H., Zhang S., Wei E., Chen Z. Carnosine ameliorates morphine-induced conditioned place preference in rats. Neurosci. Lett. 2007, 422(1):34-38.
52. Gong Y.X., Zhang W.P., Shou W.T., Zhong K., Chen Z. Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice. Neurosci. Lett. 2010, 468(2):115-119.
53. Goodchild R., Court J., Hobson I., Piggott M., Perry R., Ince P., Jaros E., Perry E. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur. J. Neurosci. 1999, 11(2):449-456.
54. Green S., Rothrock S., Gorchynski J. Validation of diphenhydramine as a dermal local anesthetic. Ann. Emerg. Med. 1994, 23(6):1284-1289.
55. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88(3):1183-1241.
56. Halpert A., Olmstead M., Beninger R. Dimenhydrinate produces a conditioned place preference in rats. Pharmacol. Biochem. Behav. 2003, 75(1):173-179.
57. Halpert A.G., Olmstead M.C., Beninger R.J. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci. Biobehav. Rev. 2002, 26(1):61-67.
58. Hasenöhrl R.U., Huston J.P. Histamine. From Messengers to Molecules: Memories are Made of These 2004, 174-195. Kluver Academic/Plenum Publishers, New York. G. Riedel, B. Platt (Eds.).
59. Hasenöhrl R., Kuhlen A., Frisch C., Galosi R., Brãndao M., Huston J. Comparison of intra-accumbens injection of histamine with histamine H1-receptor antagonist chlorpheniramine in effects on reinforcement and memory parameters. Behav. Brain Res. 2001, 124(2):203-211.
60. Hiroi T., Ohishi N., Imaoka S., Yabusaki Y., Fukui H., Funae Y. Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms. J. Pharmacol. Exp. Ther. 1995, 272(2):939-944.
61. Honrubia M., Vilaró M., Palacios J., Mengod G. Distribution of the histamine H(2) receptor in monkey brain and its mRNA localization in monkey and human brain. Synapse 2000, 38(3):343-354.
62. Humbert-Claude M., Morisset S., Gbahou F., Arrang J. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions. Biochem. Pharmacol. 2007, 73(8):1172-1181.
63. Huston J., Wagner U., Hasenöhrl R. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav. Brain Res. 1997, 83(1-2):97-105.
64. Hyman S., Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2001, 2(10):695-703.
65. Hyytiä P., Bäckström P., Piepponen P., Ahtee L. Histamine H3-receptor antagonist thioperamide potentiates behavioral effets of cocaine. Eur. J. Pharmaceut. Sci. 2003, 19:S25.
66. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 2007, 56(1):27-78.
67. Ito C., Onodera K., Sakurai E., Sato M., Watanabe T. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J. Pharmacol. Exp. Ther. 1996, 279(1):271-276.
68. Ito C., Onodera K., Sakurai E., Sato M., Watanabe T. Effect of cocaine on the histaminergic neuron system in the rat brain. J. Neurochem. 1997, 69(2):875-878.
69. Ito C., Onodera K., Watanabe T., Sato M. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats. Psychopharmacology 1997, 130(4):362-367.
70. Ito C., Onodera K., Yamatodani A., Watanabe T., Sato M. The effect of methamphetamine on histamine release in the rat hypothalamus. Psychiatry Clin. Neurosci. 1997, 51(2):79-81.
71. Itoh Y., Nishibori M., Oishi R., Saeki K. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci. Lett. 1984, 48(3):305-309.
72. Itoh Y., Oishi R., Nishibori M., Saeki K. Involvement of Mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J. Pharmacol. Exp. Ther. 1988, 244(3):1021-1026.
73. Iwabuchi K., Kubota Y., Ito C., Watanabe T., Watanabe T., Yanai K. Methamphetamine and brain histamine: a study using histamine-related gene knockout mice. Ann. N. Y. Acad. Sci. 2004, 1025:129-134.
74. Jackson D., Ross S., Larsson L. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study. Naunyn Schmiedebergs Arch. Pharmacol. 1989, 340(4):355-365.
75. Jansen F., Mochizuki T., Maeyama K., Leurs R., Timmerman H. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 362(1):60-67.
76. Johnson S., North R. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12(2):483-488.
77. Joshi V., Balsara J., Jadhav J., Chandorkar A. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice. Eur. J. Pharmacol. 1981, 69(4):499-502.
78. Kalivas P. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J. Pharmacol. Exp. Ther. 1982, 222(1):37-42.
79. Kamei J., Morita K., Miyata S., Onodera K. Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice. Psychopharmacology 2003, 166(2):176-180.
80. Karamanakos P., Pappas P., Marselos M. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors. Behav. Brain Res. 2004, 148(1-2):199-208.
81. Kim Y., Shin Y., Lee C., Song J. Block of sodium currents in rat dorsal root ganglion neurons by diphenhydramine. Brain Res. 2000, 881(2):190-198.
82. Kitanaka J., Kitanaka N., Tatsuta T., Miyoshi A., Koumoto A., Tanaka K.I., Nishiyama N., Morita Y., Takemura M. Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice. Pharmacol. Biochem. Behav. 2010, 94(3):464-470.
83. Kitanaka J., Kitanaka N., Tatsuta T., Morita Y., Takemura M. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors. Neuroscience 2007, 147(3):765-777.
84. Klapdor K., Hasenöhrl R., Huston J. Facilitation of learning in adult and aged rats following bilateral lesions of the tuberomammillary nucleus region. Behav. Brain Res. 1994, 61(1):113-116.
85. Köhler C., Swanson L., Haglund L., Wu J. The cytoarchitecture, histochemistry and projections of the tuberomammillary nucleus in the rat. Neuroscience 1985, 16(1):85-110.
86. Korotkova T., Haas H., Brown R. Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci. Lett. 2002, 320(3):133-136.
87. Kubo N., Shirakawa O., Kuno T., Tanaka C. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn. J. Pharmacol. 1987, 43(3):277-282.
88. Kubota Y., Ito C., Sakurai E., Watanabe T., Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J. Neurochem. 2002, 83(4):837-845.
89. Lapa G., Mathews T., Harp J., Budygin E., Jones S. Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties. Eur. J. Pharmacol. 2005, 506(3):237-240.
90. Lester D.B., Rogers T.D., Blaha C.D. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Ther. 2010, 16(3):137-162.
91. Leza J., Lizasoain I., Lorenzo P. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen. Pharmacol. 1991, 22(2):293-296.
92. Ligneau X., Garbarg M., Vizuete M., Diaz J., Purand K., Stark H., Schunack W., Schwartz J. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. J. Pharmacol. Exp. Ther. 1994, 271(1):452-459.
93. Ligneau X., Landais L., Perrin D., Piriou J., Uguen M., Denis E., Robert P., Parmentier R., Anaclet C., Lin J., Burban A., Arrang J., Schwartz J. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem. Pharmacol. 2007, 73(8):1215-1224.
94. Lin J., Dauvilliers Y., Arnulf I., Bastuji H., Anaclet C., Parmentier R., Kocher L., Yanagisawa M., Lehert P., Ligneau X., Perrin D., Robert P., Roux M., Lecomte J., Schwartz J. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol. Dis. 2008, 30(1):74-83.
95. Lintunen M., Hyytiä P., Sallmen T., Karlstedt K., Tuomisto L., Leurs R., Kiianmaa K., Korpi E., Panula P. Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J. 2001, 15(6):1074-1076.
96. López-Moreno J., González-Cuevas G., Moreno G., Navarro M. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict. Biol. 2008, 13(2):160-187.
97. Martinez-Mir M., Pollard H., Moreau J., Arrang J., Ruat M., Traiffort E., Schwartz J., Palacios J. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res. 1990, 526(2):322-327.
98. Masukawa Y., Suzuki T., Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology 1993, 111(2):139-143.
99. Matsunaga K., Sato T., Shuto H., Tsuruta Y., Suemaru K., Gomita Y., Oishi R. Inhibition of neuronal dopamine uptake by some antiallergic drugs. Eur. J. Pharmacol. 1998, 350(2-3):165-169.
100. McKearney J. Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey. Psychopharmacology 1982, 77(2):156-158.
101. Mickley G. Histamine H2 receptors mediate morphine-induced locomotor hyperactivity of the C57BL/6J mouse. Behav. Neurosci. 1986, 100(1):79-84.
102. Molina-Hernández A., Nuñez A., Arias-Montaño J. Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum. Neuroreport 2000, 11(1):163-166.
103. Mori T., Narita M., Onodera K., Suzuki T. Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. Nihon Shinkei Seishin Yakurigaku Zasshi 2002, 22(3):73-78.
104. Mori T., Narita M., Onodera K., Suzuki T. Involvement of histaminergic system in the discriminative stimulus effects of morphine. Eur. J. Pharmacol. 2004, 491(2-3):169-172.
105. Morisset S., Pilon C., Tardivel-Lacombe J., Weinstein D., Rostene W., Betancur C., Sokoloff P., Schwartz J., Arrang J. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. J. Pharmacol. Exp. Ther. 2002, 300(2):621-628.
106. Müller C., Carey R., Huston J., De Souza Silva M. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog. Neurobiol. 2007, 81(3):133-178.
107. Munakata M., Akaike N. Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum. J. Physiol. 1994, 480(2):233-245.
108. Munzar P., Nosál R., Goldberg S. Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats. Eur. J. Pharmacol. 1998, 363(2-3):93-101.
109. Munzar P., Tanda G., Justinova Z., Goldberg S. Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 2004, 29(4):705-717.
110. Nowak J., Maśliński C. Ethanol-induced changes of histamine content in guinea-pig brain. Pol. J. Pharmacol. Pharm. 1984, 36(6):647-651.
111. Nowak K.L., McBride W.J., Lumeng L., Li T.K., Murphy J.M. Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat. Psychopharmacology 1998, 139(1-2):108-116.
112. Nuutinen S., Karlstedt K., Aitta-Aho T., Korpi E.R., Panula P. Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology 2009, 208(1):75-86.
113. O'Driscoll W.G., Lindley G.R. Self-administration of tripelennamine by a narcotic addict. N. Engl. J. Med. 1957, 257(8):376-377.
114. Ogawa S., Yanai K., Watanabe T., Wang Z., Akaike H., Ito Y., Akaike N. Histamine responses of large neostriatal interneurons in histamine H1 and H2 receptor knock-out mice. Brain Res. Bull. 2009, 78(4-5):189-194.
115. Oishi R., Shishido S., Yamori M., Saeki K. Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 349(2):140-144.
116. Okuda T., Ito Y., Nakagawa N., Hishinuma T., Tsukamoto H., Iwabuchi K., Watanabe T., Kitaichi K., Goto J., Yanai K. Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats. Eur. J. Pharmacol. 2004, 505(1-3):135-144.
117. Okuda T., Zhang D., Shao H., Okamura N., Takino N., Iwamura T., Sakurai E., Yoshikawa T., Yanai K. Methamphetamine- and 3,4 methylenedioxymethamphetamine-induced behavioral changes in histamine H(3)-receptor knockout mice. J. Pharmacol. Sci. 2009, 111(2):167-174.
118. Olds J., Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 1954, 47(6):419-427.
119. Oroszi G., Enoch M., Chun J., Virkkunen M., Goldman D. Thr105Ile, a functional polymorphism of histamine N-methyltransferase, is associated with alcoholism in two independent populations. Alcohol Clin. Exp. Res. 2005, 29(3):303-309.
120. Palacios J., Wamsley J., Kuhar M. The distribution of histamine H1-receptors in the rat brain: an autoradiographic study. Neuroscience 1981, 6(1):15-37.
121. Panula P., Pirvola U., Auvinen S., Airaksinen M. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 1989, 28(3):585-610.
122. Papanicolaou J., Fennessy M. The acute effect of ethanol on behaviour, body temperature, and brain histamine in mice. Psychopharmacology 1980, 72(1):73-77.
123. Pellinen P., Honkakoski P., Stenbäck F., Niemitz M., Alhava E., Pelkonen O., Lang M., Pasanen M. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur. J. Pharmacol. 1994, 270(1):35-43.
124. Pellinen P., Kulmala L., Konttila J., Auriola S., Pasanen M., Juvonen R. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch. Toxicol. 2000, 74(9):511-520.
125. Pfister M., Boix F., Huston J.P., Schwarting R.K. Different effects of scopolamine on extracellular acetylcholine levels in neostriatum and nucleus accumbens measured in vivo: possible interaction with aversive stimulation. J. Neural. Transm. Gen. Sect. 1994, 97(1):13-25.
126. Picciotto M.R., Brabant C., Einstein E.B., Kamens H.M., Neugebauer N.M. Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Res. 2010, 1314:206-218.
127. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J., Arrang J. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 2002, 114(1):173-193.
128. Poet T., McQueen C., Halpert J. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab. Dispos. 1996, 24(1):74-80.
129. Poklis A. T's and blues. JAMA 1978, 240(2):108.
130. Pollard H., Moreau J., Arrang J., Schwartz J. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 1993, 52(1):169-189.
131. Prast H., Heistracher M., Philippu A. Modulation by dopamine receptors of the histamine release in the rat hypothalamus. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 347(3):301-305.
132. Prast H., Tran M.H., Lamberti C., Fischer H., Kraus M., Grass K., Philippu A. Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1999, 360(5):552-557.
133. Prell G., Bielkiewicz B., Mazurkiewicz-Kwilecki I. Rat brain histamine concentration, synthesis and metabolism: effect of acute ethanol administration. Prog. Neuropsychopharmacol. Biol. Psychiatry 1982, 6(4-6):427-432.
134. Quertemont E., Tambour S., Tirelli E. The role of acetaldehyde in the neurobehavioral effects of ethanol: a comprehensive review of animal studies. Prog. Neurobiol. 2005, 75(4):247-274.
135. Rassnick S., Kornetsky C. L-histidine attenuates the effects of pentazocine on rewarding brain-stimulation. Life Sci. 1991, 48(18):1729-1736.
136. Rawat A. Development of histaminergic pathways in brain as influenced by maternal alcoholism. Res. Commun. Chem. Pathol. Pharmacol. 1980, 27(1):91-103.
137. Reuter M., Jeste N., Klein T., Hennig J., Goldman D., Enoch M., Oroszi G. Association of THR105Ile, a functional polymorphism of histamine N-methyltransferase (HNMT), with alcoholism in German Caucasians. Drug Alcohol Depend. 2007, 87(1):69-75.
138. Rubinstein M., Gershanik O., Stefano F. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice. Eur. J. Pharmacol. 1988, 148(3):419-426.
139. Ryu J., Yanai K., Iwata R., Ido T., Watanabe T. Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain. Neuroreport 1994, 5(5):621-624.
140. Sánchez-Lemus E., Arias-Montaño J. Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci. Lett. 2004, 364(3):179-184.
141. Sander K., Kottke T., Stark H. Histamine H3 receptor antagonists go to clinics. Biol. Pharm. Bull. 2008, 31(12):2163-2181.
142. Sannerud C.A., Kaminski B.J., Griffiths R.R. Maintenance of H1 antagonists self-injection in baboons. Exp. Clin. Exp. Psychopharmacol. 1995, 3:26-32.
143. Sansone M., Castellano C., D'Amato F. Enhancement of morphine-induced hyperactivity by antihistaminic drugs in mice. Arch. Int. Pharmacodyn. Ther. 1986, 284(2):239-245.
144. Sansone M., D'Udine B., Renzi P., Vetulani J. Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice. Psychopharmacology 1987, 93(2):155-157.
145. Schlicker E., Fink K., Detzner M., Göthert M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J. Neural. Transm. Gen. Sect. 1993, 93(1):1-10.
146. Segura-Torres P., Wagner U., Massanes-Rotger E., Aldavert-Vera L., Marti-Nicolovius M., Morgado-Bernal I. Tuberomammillary nucleus lesion facilitates two-way active avoidance retention in rats. Behav. Brain Res. 1996, 82(1):113-117.
147. Sharma A., Hamelin B. Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view. Curr. Drug Metab. 2003, 4(2):105-129.
148. Shishido S., Oishi R., Saeki K. In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 1991, 343(2):185-189.
149. Shippenberg T.S., LeFevour A., Chefer V.I. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol. Disord. Drug Targets 2008, 7(5):442-453.
150. Showalter C. T's and blues. Abuse of pentazocine and tripelennamine. JAMA 1980, 244(11):1224-1225.
151. Southam E., Cilia J., Gartlon J., Woolley M., Lacroix L., Jennings C., Cluderay J., Reavill C., Rourke C., Wilson D., Dawson L., Medhurst A., Jones D. Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. Psychopharmacology 2009, 201(4):483-494.
152. Starr B., Starr M., Kilpatrick I. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience 1987, 22(1):179-188.
153. Subramanian N., Mitznegg P., Estler C. Ethanol-induced alterations in histamine content and release in the rat hypothalamus. Naunyn Schmiedebergs Arch. Pharmacol. 1978, 302(1):119-121.
154. Subramanian N., Mulder A. Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur. J. Pharmacol. 1977, 43(2):143-152.
155. Subramanian N., Schinzel W., Mitznegg P., Estler C. Influence of ethanol on histamine metabolism and release in the rat brain. II. Regions of the histaminergic pathway. Pharmacology 1980, 20(1):42-45.
156. Sulzer D., Sonders M., Poulsen N., Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 2005, 75(6):406-433.
157. Suzuki T., Masukawa Y., Misawa M. Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology 1990, 102(4):438-442.
158. Suzuki T., Masukawa Y., Shiozaki Y., Misawa M. Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology 1991, 105(1):9-12.
159. Suzuki T., Mori T., Takamori K., Onodera K., Misawa M. Effects of H(1)-antagonists on discriminative stimulus effects of cocaine and methamphetamine in rats. Behav. Pharmacol. 1996, 7(2):111-118.
160. Suzuki T., Mori T., Tsuji M., Misawa M., Onodera K. Generalization of D-L- and DL-chlorpheniramine and zolantidine to the discriminative stimulus effects of cocaine and methamphetamine. Behav. Pharmacol. 1997, 8(8):718-724.
161. Suzuki T., Mori T., Tsuji M., Misawa M., Onodera K. Interactions between H1-antagonists and opioids: a drug discrimination study. Psychopharmacology 1997, 131(4):346-353.
162. Suzuki T., Mori T., Tsuji M., Nomura M., Misawa M., Onodera K. Evaluation of the histamine H1-antagonist-induced place preference in rats. Jpn. J. Pharmacol. 1999, 81(4):332-338.
163. Suzuki T., Takamori K., Misawa M., Onodera K. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res. 1995, 675(1-2):195-202.
164. Takino N., Sakurai E., Kuramasu A., Okamura N., Yanai K. Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice. Int. Rev. Neurobiol. 2009, 85:109-116.
165. Tanda G., Kopajtic T., Katz J. Cocaine-like neurochemical effects of antihistaminic medications. J. Neurochem. 2008, 106(1):147-157.
166. Toyota H., Dugovic C., Koehl M., Laposky A., Weber C., Ngo K., Wu Y., Lee D., Yanai K., Sakurai E., Watanabe T., Liu C., Chen J., Barbier A., Turek F., Fung-Leung W., Lovenberg T. Behavioral characterization of mice lacking histamine H(3) receptors. Mol. Pharmacol. 2002, 62(2):389-397.
167. Traiffort E., Pollard H., Moreau J., Ruat M., Schwartz J., Martinez-Mir M., Palacios J. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. J. Neurochem. 1992, 59(1):290-299.
168. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151(2-3):99-120.
169. Vengeliene V., Bilbao A., Molander A., Spanagel R. Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 2008, 154(2):299-315.
170. Vizuete M., Traiffort E., Bouthenet M., Ruat M., Souil E., Tardivel-Lacombe J., Schwartz J. Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience 1997, 80(2):321-343.
171. Wagner U., Segura-Torres P., Weiler T., Huston J. The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions. Brain Res. 1993, 613(2):269-274.
172. Wagner U., Weiler H.T., Huston J.P. Amplification of rewarding hypothalamic stimulation following a unilateral lesion in the region of the tuberomammillary nucleus. Neuroscience 1993, 52(4):927-932.
173. Wang H.J., Lu M., Gong Y.X., Chen Z. Effects of clobenpropit and histidine on reinstatement of morphine-induced conditioned place preference. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009, 38(6):559-564.
174. Wang Z., Woolverton W. Self-administration of cocaine-antihistamine combinations: super-additive reinforcing effects. Eur. J. Pharmacol. 2007, 557(2-3):159-160.
175. Wang Z., Woolverton W. Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys. Pharmacol. Biochem. Behav. 2009, 91(4):590-595.
176. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr. Opin. Pharmacol. 2005, 5(1):9-19.
177. Wise R., Bozarth M. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987, 94(4):469-492.
178. Woolverton W., Wang Z., Vasterling T., Carroll F., Tallarida R. Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of action. Psychopharmacology 2008, 196(4):575-582.
179. Wu D., Otton S., Inaba T., Kalow W., Sellers E. Interactions of amphetamine analogs with human liver CYP2D6. Biochem. Pharmacol. 1997, 53(11):1605-1612.
180. Yang R., Hey J., Aslanian R., Rizzo C. Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes. Pharmacology 2002, 66(3):128-135.
181. Zacny J. Discriminative stimulus effects of H(1)-anti-histamines in cocaine-trained pigeons. Behav. Pharmacol. 1989, 1(3):261-265.
182. Zarrindast M., Moghimi M., Rostami P., Rezayof A. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism. Brain Res. 2006, 1109(1):108-116.
183. Zimatkin S., Anichtchik O. Alcohol-histamine interactions. Alcohol Alcohol. 1999, 34(2):141-147.
184. Zimatkin S.M., Liopo A.V., Zakharov O., Yu Effects of histamine H1 receptor antagonists on alcohol related behavior and ethanol metabolism. Alcohol Alcohol. 1997, 32:361.
185. Zimmermann P., Privou C., Huston J. Differential sensitivity of the caudal and rostral nucleus accumbens to the rewarding effects of a H1-histaminergic receptor blocker as measured with place-preference and self-stimulation behavior. Neuroscience 1999, 94(1):93-103.
186. Zimmermann P., Privou C., Wagner U., Huston J. Lateralized attenuation of hypothalamic self-stimulation after injecting histamine synthesis blocker alpha-FMH into the E2 tuberomammillary subnucleus. Brain Res. Bull. 1997, 44(1):85-90.